The US Food and Drug Administration has approved a new once-daily oral tablet for the treatment of osteoarthritis pain. The drug also contains a built-in antihypertensive.
The US Food and Drug Administration has approved a new once-daily oral tablet for the treatment of osteoarthritis pain. The drug also contains a built-in antihypertensive.
The US Food and Drug Administration has approved a new once-daily oral tablet for the treatment of osteoarthritis pain. The drug also contains a built-in antihypertensive.
The US Food and Drug Administration has approved the expansion of the indication of tofacitinib to include some adults with ulcerative colitis, making it the first oral medication approved for chronic use...
The US Food and Drug Administration has approved the expansion of the indication of tofacitinib to include some adults with ulcerative colitis, making it the first oral medication approved for chronic use...
The US Food and Drug Administration has approved the expansion of the indication of tofacitinib to include some adults with ulcerative colitis, making it the first oral medication approved for chronic use...
The US Food and Drug Administration has approved a new product for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause.
The US Food and Drug Administration has approved a new product for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause.
The US Food and Drug Administration has approved a new product for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause.
